TRIALHEALTH

Serial Number 98802414
645

Registration Progress

Application Filed
Oct 15, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Final Refusal E-Mailed
Due: Feb 07, 2026 20 days

Trademark Image

TRIALHEALTH

Basic Information

Serial Number
98802414
Filing Date
October 15, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
645
Status Date
Nov 7, 2025
Application
Pending
Classes
035

Rights Holder

Synexus Clinical Research US, Inc.

03
Address
929 North Front Street
Wilmington, NC 28401

Ownership History

Synexus Clinical Research US, Inc.

Original Applicant
03
Wilmington, NC

Legal Representation

Attorney
Kenya Williams

USPTO Deadlines

Next Deadline
20 days remaining
Final Refusal E-Mailed
Due Date
February 07, 2026
Extension Available
Until May 07, 2026

Application History

14 events
Date Code Type Description Documents
Nov 7, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 7, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 7, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 21, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 20, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 20, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 17, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jul 17, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Apr 18, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 18, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 18, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 17, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 16, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 15, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business management of clinical trials for others; recruitment of clinical drug trial participants, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; marketing of healthcare and pharmaceutical products of others; compiling information into computer databases, namely, collecting and compiling consumer preference information regarding health conditions, clinical trial participation interest, and clinical trial candidacy for business purposes; collection of market research information, namely, collecting and compiling clinical trial statistics and information for business purposes

Additional Information

Pseudo Mark
TRIAL HEALTH

Classification

International Classes
035